Breaking News:Against Jeff Sessions for Attorney General

Executive Branch

RSS Feed for this category

Chronicle AM: Clinton Renews Rescheduling Call, Kerry Gets MX Human Rights Letter, More... (8/12/16)

The DEA's refusal to reschedule marijuana yesterday elicits reactions from Hillary Clinton and DC activists, a California bill to tax medical marijuana farmers dies in committee, Secretary of State Kerry gets a letter from Congress urging him to prioritize human rights when it comes to financing Mexico's drug war, and more.

DC activists are set to give the White House an earful after the DEA refused to reschedule marijuana.
Marijuana Policy

In Wake of DEA Decision, Hillary Clinton Reiterates Call for Rescheduling Marijuana. Democratic presidential candidate Hillary Clinton will move to reclassify marijuana as a Schedule II substance, her campaign said in a statement after the DEA rejected reclassification Thursday. "As president, Hillary will build on the important steps announced today by rescheduling marijuana from a Schedule I to a Schedule II substance. She will also ensure Colorado, and other states that have enacted marijuana laws, can continue to serve as laboratories of democracy," senior Clinton advisor Maya Harris said.

In Wake of DEA Decision, Emergency Demonstration at the White House Tonight. Washington, DC, DCMJ legalization activists are gathering in front of the White House tonight at 8:20 PM to protest the DEA's refusal to move marijuana from Schedule I, the same schedule as heroin. "Here we are, 43 years and millions of marijuana arrests later, and we being told that cannabis is still as dangerous as heroin. WHAT THE HELL?!?!" organizers wrote on Facebook. "The Obama Administration's DEA thinks Americans should go to jail for a non-toxic plant. WE THINK OTHERWISE!"

Medical Marijuana

California Medical Marijuana Tax Bill Dies in Committee. A bill that would have imposed a tax on commercial medical marijuana growers has been killed in the Senate Appropriations Committee. Assembly Bill 2243 would have imposed a tax of up to $9.25 per ounce of marijuana buds, $2.75 for pot leaves, and $1.25 for immature pot plants. The panel killed the bill after patient advocates said it would impose a burden on patients.

International

Canadian Medical Marijuana Patients Will Be Able to Grow Their Own. Health Canada said Thursday that medical marijuana patients will be able to grow limited amounts for themselves or have a caregiver do so. The move comes as the government attempts to comply with a federal court ruling that struck down the previous Conservative government's ban on patients growing their own. Patients would also still have the option of buying from one of 34 producers licensed by the federal government.

Congresspersons Sign Letter to Secretary of State Kerry Urging That US Prioritize Human Rights in Mexico. Some 68 members of Congress have signed onto a letter urging Kerry to make human rights a priority in US relations with Mexico. The letter expresses concern over the "27,000 unresolved cases of people who have disappeared in Mexico since 2007, and the slow pace of reforms in the military, law enforcement and justice sectors," as well as the persistent use of torture in criminal investigations. It calls for US support for the ongoing investigation and search for the 43 disappeared students from the Ayotzinapa rural teachers' college. And it reiterates the need for accountability and justice in the cases of grave abuses committed by Mexican security forces in Oaxaca and Tlatlaya. The letter comes as the State Department is reviewing the Mexican government's compliance with human rights conditions attached to US anti-drug funding.

(This article was prepared by StoptheDrugWar.org"s lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

DEA's Marijuana Rescheduling Rejection Is Disappointing, But Doesn't Have Much Impact [FEATURE]

This article was produced in collaboration with AlterNet and an earlier version appeared here.

The DEA's decision Thursday not to move marijuana from Schedule I of the Controlled Substances Act (CSA) ended months of speculation about whether the agency would finally act in accordance with an ever-increasing mountain of evidence of marijuana's medicinal utility and either schedule it less restrictively or deschedule it altogether.

Supporters of more enlightened marijuana policies were disappointed, but not surprised. After all, the DEA has a long history of rejecting and impeding science when it comes to marijuana. But even had DEA acted (it did ease the University of Mississippi's monopoly on growing marijuana for research purposes), the most likely move would have been grudgingly incremental, shifting marijuana from a schedule where it is grouped with heroin down to Schedule II, where it would be grouped with cocaine and methamphetamines, and still not prescribable absent FDA approval.

Or the agency could have taken some other largely unpalatable stance, such as making cannibidiol a Schedule III substance (like synthetic Marinol) while leaving the whole plant Schedule I. In any case, any move short of descheduling it entirely and treating it like alcohol and tobacco, would have left marijuana medicalized, but not normalized.

The article below was written days before the DEA's decision, but we think the discussion remains germane for understanding the issues around rescheduling and why most reformers are disappointed, but not devastated by the agency's stubborn refusal to budge.

While the DEA may move to reschedule marijuana to a lesser schedule, keeping it within the purview of the Controlled Substances Act means that it would still be illegal, even for medical use in the absence of FDA approval. Even with FDA approval, a years-long process, it would still require a prescription to obtain, which would do nothing to address legal adult marijuana sales, production, or possession in the states. Removing it from the CSA, or descheduling, is what consumers and the industry are calling for, but that is the unlikeliest outcome, even though that's how we deal with the two most commonly used recreational drugs in the United States, alcohol and tobacco.

Schedule I is reserved for substances that have "no currently accepted medical use and a high potential for abuse," the DEA notes. "Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence." Those drugs include heroin, Ecstasy, LSD, peyote…and marijuana.

For more than 40 years, the DEA has blocked efforts to have marijuana placed in a more appropriate schedule, one that reflects the plant's medicinal uses as well as its relative harmlessness compared to other scheduled substances. But that stance has grown increasingly untenable in the face of state-level medical marijuana programs and in the face of an ever-larger mountain of research that fails to find significant serious health consequences from marijuana use.

Now, the DEA is considering a decision on the most recent rescheduling petition. Earlier this year, the agency told lawmakers it "hopes to release its determination in the first half of 2016," but that clearly didn't happen. Late in June, DEA spokesman Russ Baer said the agency is "in the final stages" of making its determination. And just last week, Baer said, "We're closer than we ever were. It's a very deliberative process."

If the DEA decides not to keep marijuana in Schedule I, the most obvious incremental move would be for it to bump it down one step to Schedule II, placing pot in the same category as morphine, cocaine, and methamphetamine. That could pave the way for eventually allowing doctors to prescribe it, and would remove some roadblocks to further research. It might open the way for broader changes in financial and business regulations, although a shift to Schedule III or greater would be needed to address the debilitating 280E tax provision, which prevents cannabusinesses from deducting ordinary expenses like rent or payroll.

The DEA still doesn't see the "medical" in "medical marijuana." (Wikimedia/Creative Commons)
But Schedule II, or any of the lesser schedules, would require that marijuana be approved by Food and Drug Administration (FDA), a lengthy and expensive process that could bankrupt businesses attempting to overcome those regulatory hurdles. And until that happens, there is no approved marijuana for doctors to prescribe. It's also unclear whether the FDA would ever approve smoked marijuana.

Members of the marijuana industry, medical marijuana advocates, and marijuana consumer advocacy groups alike expressed skepticism about the DEA's willingness or ability to respond to the scientific evidence, uncertainty about what the agency was likely to do, and a demonstrated a pronounced -- if not unanimous -- preference not for rescheduling, but for descheduling.

Matthew Huron is a founder and former board member of the National Cannabis Industry Association and founder and current CEO of Good Chemistry Colorado, a vertically integrated cannabis company, as well as the co-founder of the Wellspring Collective, which caters to seniors with health challenges. Huron isn't exactly enthused by the prospect of Schedule II.

"Just to move it to Schedule II is more complicated than we're reading about," he said. "It might just be the molecule that gets rescheduled -- not cannabis. I don't think moving it to Schedule II would really have much effect on the states. It wouldn't hurt, but it wouldn't really help. Most of us in the industry would like to see it descheduled."

The medical marijuana advocacy group Americans for Safe Access (ASA) is pushing for Schedule II, but it's not relying on the DEA to make it happen.

"We don't have a crystal ball, and we don't know what the DEA will do, but based on past history, we don't have high hopes they will reschedule," said ASA spokesperson Melissa Wilcox. "It's possible they will de- or reschedule CBD and leave whole plant cannabis at Schedule I. Who knows? The DEA tends to ignore the science."

Schedule II "would remove barriers to scientists wishing to do research, so we know best how to use cannabis -- targeting, dosing, all the questions we haven't been able to study because it is such a pain to get research done now," said Wilcox.

But with little faith in the DEA, ASA is instead pushing for a legislative solution, the Compassionate Access, Research Expansion, and Respect States' Rights (CARERS) Act, also known as S. 683, which is currently bottled up in the Senate Judiciary Committee, chaired by octogenarian prohibitionist Sen. Chuck Grassley (R-IA).

The CARERS Act would move marijuana to Schedule II, as well as deschedule CBD, open up access to marijuana business banking, and end the NIDA monopoly on growing marijuana for research, among other provisions.

"We're pretty sure this could pass, but Grassley is the gatekeeper, and we're pushing hard to get him to schedule a vote," said Wilcox.

"Moving marijuana to Schedule II is not a solution," said Mason Tvert, communications director for the Marijuana Policy Project, which has played -- and continues to play -- a major role in advancing both medical marijuana and legalization at the state level. "It would certainly remove barriers to research, but it would still treat marijuana as if it were as harmful as cocaine and other illegal substances, when it is objectively less harmful than alcohol. We fully support removing marijuana from the schedules and treating it like alcohol," Tvert emphasized.

"We think marijuana should be removed entirely from the Controlled Substances Act," said Dale Gieringer, long-time head of California NORML, representing consumers and small growers in the nation's most populous state. "As a fallback position, we've been litigating since 1972 to get it rescheduled to Schedule II. If they do that, that would be good -- they'd only be 45 years overdue," he noted.

"From the standpoint of states that have state-legal suppliers, Schedule II doesn't accomplish a whole lot," Gieringer said. "Those state-legal suppliers wouldn't become federally legal; they'd have to first obtain FDA approval. Until that happens, everybody is an illegal producer of a scheduled drug under federal law," he said.

"Schedule II would allow doctors to write prescriptions -- but nobody could fill them," Gieringer noted. "There are international prescriptions and international suppliers, though. But the main impact would be doctors would feel better and cops couldn't argue that marijuana isn't a medicine. If they're trying to create a niche for existing legal medical marijuana state, putting it in Schedule II is like creating a square hole for a round peg."

Marijuana patients, consumers, and the industry are all waiting for the DEA to act, but aren't really holding out much hope it will do the right thing. And even the half-steps it might take, such as moving it to Schedule II or separating out CBDs for lower scheduling, aren't going to substantially alter marijuana's legal status or resolve the conflicts between state-level legality and federal marijuana prohibition. When it comes to rescheduling marijuana, there's just not that much there there.

Medical Marijuana Update

The DEA again rejects marijuana rescheduling, a North Dakota initiative makes the ballot, a South Dakota one doesn't, a Missouri one hangs on by a thread, and more.

National

On Thursday, DEA again refused to reschedule marijuana. The DEA today again refused to reschedule marijuana, arguing that its therapeutic value has not been scientifically proven. The move rejecting a rescheduling petition from two governors comes despite medical marijuana being legal in half the states and in the face of an ever-increasing mountain of evidence of marijuana's medicinal utility. Today's action marks at least the fourth time the DEA has rejected petitions seeking to reschedule marijuana. The effort to get the DEA to move marijuana off the same schedule as heroin has been going on since 1972, and once again has garnered the same result. The agency did announce one policy change that could make it easier to conduct marijuana research. It said it would end the University of Mississippi's monopoly on the production of marijuana for research purposes by granting growing licenses to a limited number of other universities.

Missouri

On Monday, a medical marijuana initiative campaign vowed to go to court to try to overturn invalidated signatures. New Approach Missouri announced that it will go to court this month to overturn invalidated signatures so that its medical marijuana initiative can appear on the November ballot. The campaign has enough valid signatures to qualify in every congressional district except the state's second, where local election officials invalidated more than 10,000 signatures, leaving the campaign roughly 2,200 short of the 32,337 required in that district.

Ohio

On Tuesday, Ohio took the first step toward getting medical marijuana up and running. The state Medical Marijuana Control Program has unveiled a website with the first information on how it plans to implement the state's new medical marijuana law. Medical marijuana will not be available before September 2018, as the state works to develop rules and regulations.

North Dakota

On Tuesday, a medical marijuana initiative qualified for the November ballot. The secretary of state's office has confirmed that Compassionate Care Act initiative has submitted enough valid signatures to qualify for the November ballot. The initiative would allow patients suffering from a list of specified medical conditions to possess up to three ounces of marijuana and grow their own if they are more than 40 miles away from a licensed dispensary. Dispensaries would be nonprofits.

South Dakota

On Tuesday, a state court judge rejected a medical marijuana initiative campaign's appeal. The state will not be voting on the issue this November after a state court judge denied a request from the campaign to overturn Secretary of State Shantel Krebs' finding that the group did not hand in enough valid voter signatures to qualify for the ballot. South Dakota has twice previously rejected medical marijuana at the polls -- the only state to do so.

[For extensive information about the medical marijuana debate, presented in a neutral format, visit MedicalMarijuana.ProCon.org.]

Chronicle AM: DEA Rejects MJ Rescheduling, AZ Legalization Init Makes Ballot, More... (8/11/16)

The DEA is up to the same old same old, Arizona joins the list of states voting on marijuana legalization this fall, heroin overdoses jump in recent years in New York, and more.

Marijuana Policy

DEA Again Refuses to Reschedule Marijuana. The DEA today again refused to reschedule marijuana, arguing that its therapeutic value has not been scientifically proven. The move rejecting a rescheduling petition from two governors comes despite medical marijuana being legal in half the states and in the face of an ever-increasing mountain of evidence of marijuana's medicinal utility. Today's action marks at least the fourth time the DEA has rejected petitions seeking to reschedule marijuana. The effort to get the DEA to move marijuana off the same schedule as heroin has been going on since 1972, and once again has garnered the same result. The agency did announce one policy change that could make it easier to conduct marijuana research. It said it would end the University of Mississippi's monopoly on the production of marijuana for research purposes by granting growing licenses to a limited number of other universities.

Arizona Legalization Initiative Qualifies for November Ballot. It's official: State officials have confirmed that the initiative from the Campaign to Regulate Marijuana Like Alcohol has gathered enough valid voter signatures to qualify for the November ballot. The initiative will appear on the ballot as Proposition 205.

Heroin and Prescription Opioids

Fatal Overdoses Have Jumped in New York City in Recent Years. Fatal drug overdoses have jumped 66% in the city between 2010 and 2015, the city Department of Health and Mental Hygiene Reported Tuesday. Last year, 937 New Yorkers died of overdoses, compared to 541 in 2010. Heroin was involved in 59% of the deaths.

International

Vietnam Sentences Nine to Death for Smuggling Heroin to China. A court in Lang Son has handed out death sentences to nine men for smuggling about 500 pounds of heroin to China. Two others were sentenced to life in prison. Under Vietnamese law, possession or sale of more than 100 grams of heroin is punishable by death.

DEA Once Again Refuses to Reschedule Marijuana, But Does Offer One Sop [FEATURE]

The DEA today again refused to reschedule marijuana, arguing that its therapeutic value has not been scientifically proven. The move rejecting a rescheduling petition from two governors comes despite medical marijuana being legal in half the states and in the face of an ever-increasing mountain of evidence of marijuana's medicinal utility.

"DEA has denied two petitions to reschedule marijuana under the Controlled Substances Act (CSA)," the agency said in a press release. "In response to the petitions, DEA requested a scientific and medical evaluation and scheduling recommendation from the Department of Health and Human Services (HHS), which was conducted by the U.S. Food and Drug Administration (FDA) in consultation with the National Institute on Drug Abuse (NIDA). Based on the legal standards in the CSA, marijuana remains a schedule I controlled substance because it does not meet the criteria for currently accepted medical use in treatment in the United States, there is a lack of accepted safety for its use under medical supervision, and it has a high potential for abuse."

Today's action marks at least the fourth time the DEA has rejected petitions seeking to reschedule marijuana. The effort to get the DEA to move marijuana off the same schedule as heroin has been going on since 1972, and once again has garnered the same result.

The move comes despite the expansion of state medical marijuana laws at least three more states will vote on it this year -- and a growing clamor for change, including from members of Congress. Just yesterday, the National Conference of State Legislatures adopted a resolution calling on the federal government to move marijuana off Schedule I.

The agency did announce one policy change that could make it easier to conduct marijuana research. It said it would end the University of Mississippi's monopoly on the production of marijuana for research purposes by granting growing licenses to a limited number of other universities.

But that was not nearly enough for marijuana reform advocates, who scorched the agency for its continuing refusal to move the drug off of Schedule I, if not outside the purview of the Controlled Substances Act altogether.

"This decision is further evidence that the DEA doesn't get it. Keeping marijuana at Schedule I continues an outdated, failed approach -- leaving patients and marijuana businesses trapped between state and federal laws," said Rep. Earl Blumenauer (D-OR).

The DEA again refuses to acknowledge marijuana's medicinal utility. (Creative Commons/Wikipedia)
"The DEA's refusal to remove marijuana from Schedule I is, quite frankly, mind-boggling. It is intellectually dishonest and completely indefensible. Not everyone agrees marijuana should be legal, but few will deny that it is less harmful than alcohol and many prescription drugs. It is less toxic, less addictive, and less damaging to the body," said Mason Tvert, communications director for the Marijuana Policy Project.

"We are pleased the DEA is finally going to end NIDA's monopoly on the cultivation of marijuana for research purposes. For decades it has been preventing researchers from exploring the medical benefits of marijuana. It has also stood in the way of any scientific inquiries that might contradict the DEA's exaggerated claims about the potential harms of marijuana or raise questions about its classification under Schedule I," Tvert continued.

"The DEA's announcement is a little sweet but mostly bitter. Praising them for it would be like rewarding a student who failed an exam and agreed to cheat less on the next one. Removing barriers to research is a step forward, but the decision does not go nearly far enough. Marijuana should be completely removed from the CSA drug schedules and regulated similarly to alcohol," he concluded.

"For far too long, federal regulations have made clinical investigations involving cannabis needlessly onerous and have placed unnecessary and arbitrary restrictions on marijuana that do not exist for other controlled substances, including some other schedule I controlled substances," said Paul Armentano, deputy director of NORML.

"While this announcement is a significant step toward better facilitating and expanding clinical investigations into cannabis' therapeutic efficacy, ample scientific evidence already exists to remove cannabis from its schedule I classification and to acknowledge its relative safety compared to other scheduled substances, like opioids, and unscheduled substances, such as alcohol," he continued. "Ultimately, the federal government ought to remove cannabis from the Controlled Substances Act altogether in a manner similar to alcohol and tobacco, thus providing states the power to establish their own marijuana regulatory policies free from federal intrusion.

It is time for Congress to step up, Armentano said.

The DEA's approach. (DEA)
"Since the DEA has failed to take such action, then it is incumbent that members of Congress act swiftly to amend cannabis' criminal status in a way that comports with both public and scientific opinion. Failure to do so continues the federal government's 'Flat Earth' position; it willfully ignores the well-established therapeutic properties associated with the plant and it ignores the laws in 26 states recognizing marijuana's therapeutic efficacy," he said.

He wasn't the only one.

"It's really sad that DEA has chosen to continue decades of ignoring the voices of patients who benefit from medical marijuana," said Tom Angell, chairman of Marijuana Majority. "President Obama always said he would let science -- and not ideology -- dictate policy, but in this case his administration is upholding a failed drug war approach instead of looking at real, existing evidence that marijuana has medical value. This unfortunate decision only further highlights the need for Congress to pass legislation curtailing the ability of DEA and other federal agencies to interfere with the effective implementation of state marijuana laws. A clear and growing majority of American voters support legalizing marijuana outright and the very least our representatives should do is let states implement their own policies, unencumbered by an outdated 'Reefer Madness' mentality that some in law enforcement still choose to cling to."

Given that the DEA and the executive branch have proven -- once again! -- unwilling to remove the ideological blinders from their eyes, it is now indeed up to Congress. Perhaps after this coming election cycle, in which we are likely to see more states vote to approve medical marijuana and even more vote to just legalize it, Congress will see the writing on the wall.

Washington, DC
United States

Chronicle AM: WA Legal MJ Sales Top $1 Billion, AR Welfare Drug Testing Flop, More... (8/5/16)

Arizona legalizers fight a lawsuit aimed at knocking them off the ballot, Washington rakes in the tax revenue from legal pot, asset forfeiture is in the news in California and New York, and more.

Arkansas forced 800 welfare applicants to do drug screens, one came up dirty. (Wikimedia/Creative Commons)
Marijuana Policy

Arizona Legalization Campaign Wants Lawsuit Tossed. The group behind the state's legalization initiative has asked a judge to throw out a lawsuit filed by foes seeking to keep the measure off the November ballot. The Campaign to Regulate Marijuana Like Alcohol argued that the effort is more about politics and ideology than ensuring state law is followed. Foes argued that the ballot measure's summary language does not describe everything the initiative would do. Both sides will be in court a week from today.

In Face of Uproar, Oregon US Attorney Drops Federal Marijuana Charge Against Teen for One Gram of Weed. Rather than prosecute Devontre Thomas, 19, for possession of a gram of marijuana, federal prosecutors have agreed to enter him into a pretrial diversion program. The move comes after Oregon elected officials said the prosecution was overkill.

Washington State Sees Legal Marijuana Sales Push Past Billion Dollar Mark. After a sharp jump in adult sales last month as medical dispensaries were shut down, the state has now seen pot sales edge past a billion dollars, if revenue from processors and producers is included. The state has collected $273 million in excise taxes on the sales since they began two years ago.

Asset Forfeiture

California Asset Forfeiture Reform Bill Set to Move After Compromise. After discussions with law enforcement groups, state Sen. Holly Mitchell (D-Los Angeles) has amended her asset forfeiture reform bill, Senate Bill 443, so that only property seizures worth less than $40,000 would require a criminal conviction before permanent seizure. Seizures higher than that amount would not require that standard of proof. Mitchell said the compromise would allow police to preserve their ability to go after large criminal enterprises. The police groups have now dropped their opposition to the bill.

NYPD Sued for Failure to Release Asset Forfeiture Data. NYPD collected more than $6 million in asset forfeiture revenues in 2013, but is ignoring records requests for information on how it collects and distributes the cash it seizes, according to a lawsuit filed Thursday by a legal aid group representing low-income people. The group, Bronx Defenders, had submitted a public records request nearly two years, but NYPD has been unresponsive, the lawsuit alleges.

Drug Testing

Arkansas Welfare Drug Test Program Finds Hardly Any Drug Users. According to data released this week by the Department of Workforce Services, exactly one welfare applicant out of 800 has failed a drug test. Another four refused to take it, rendering them temporarily ineligible for benefits. All five taken together constitute 0.63% of welfare applicants. The one failed drug test means 0.125% of all applicants tested positive. Arkansas and other states that have enacted such laws have done so on the unspoken assumption that welfare applicants are using drugs at the taxpayers' expense, but, once again, that has proven not to be the case.

Chronicle AM: Obama Commutes More Drug Sentences, Boston's First MedMJ Shop Opens, More... (8/3/16)

Obama commutes more drug sentences, Boston gets its first dispensary, more signs of how horrid South Dakota is on marijuana, Utah SWAT deployment data, and more.

Utah SWAT is aimed mostly at drug offenders. (Wikipedia/Creative Commons)
Marijuana Policy

Oregon US Attorney Prosecuting Black Teen Over One Gram of Weed. In the first federal marijuana possession prosecution in the state in five years, teenager Devontre Thomas has been charged over a gram of pot found in another student's backpack at the federal Indian School they both attended. The other teen claimed he got the weed from Thomas, and that's enough for US Attorney Billy J. Williams to charge Thomas with "knowingly and intentionally possessing marijuana." Williams is getting blowback from many, including US Sen. Jeff Merkley (D-OR), who said "situations like this are best handled by the state."

South Dakota to Prosecute Consultants for Aborted Indian Tribe Pot Grow. Attorney General Marty Jackley announced Wednesday that two men who consulted with the Flandreau Santee Sioux Tribe in its effort to grow marijuana have been indicted on a range of marijuana possession charges. The tribe began to grow after the federal government signaled that tribes could do so, but destroyed its crop after federal officials raided other tribes than had entered the business and after state officials threatened to arrest non-Indians who used marijuana there. One of the consultants was hit with felony possession and is looking at up to 7 ½ years in prison, while the other, who cooperated with authorities, only got a misdemeanor charge.

Medical Marijuana

Boston Gets Its First Dispensary. The Patriot Cares dispensary is open on Boston's Milk Street as of today. The company says it's ready for 150 patients a day and that 200 patients have already registered.

South Dakota Medical Marijuana Initiative Supporters Sue Over Signatures. The secretary of state's office said petitions from the South Dakota Coalition for Compassion came up short on signatures, blocking the measure from going to the voters, and now, the coalition has filed a complaint alleging that signatures were not properly counted. The coalition is seeking to have the secretary of state's decision thrown out and that a local judge will order the initiative placed on the November ballot.

Law Enforcement

Utah SWAT Used Overwhelmingly for Drug Crimes. Utah is the only state to currently require reporting on SWAT deployments, and the 2015 report has just been released. SWAT was deployed 457 times in 2015, including 281 forced entries into private residences. Three-quarters of those forced entries were drug raids. The data also showed that police were more likely to use "no-knock" search warrants against drug suspects than against violent crime suspects. Go figure.

Pardons and Clemency

Obama Frees More Federal Drug Prisoners, But Time is Running Out. Some 214 federal drug war prisoners saw their prison sentences commuted Wednesday as President Obama took another step toward fulfilling his administration's pledge to use his pardon power to cut draconian drug sentences and free prisoners serving decades-long stretches for non-violent drug crimes.Those whose sentences were commuted Wednesday will walk out of prison on December 1. With Wednesday's commutations, Obama has now commuted the sentences of 562 men and women sentenced under harsh federal drug laws, including 197 people doing life for drug offenses. That's more commutations than the last nine presidents combined.

Obama Frees More Federal Drug War Prisoners, But Time is Running Out

Some 214 federal drug war prisoners saw their prison sentences commuted Wednesday as President Obama took another step toward fulfilling his administration's pledge to use his pardon power to cut draconian drug sentences and free prisoners serving decades-long stretches for nonviolent drug crimes.

"The power to grant pardons and commutations… embodies the basic belief in our democracy that people deserve a second chance after having made a mistake in their lives that led to a conviction under our laws," the president said.

Those whose sentences were commuted Wednesday will walk out of prison on December 1.

With Wednesday's commutations, Obama has now commuted the sentences of 562 men and women sentenced under harsh federal drug laws, including 197 people doing life for drug offenses. That's more commutations than the last nine presidents combined.

But it's not close to the number whose sentences Obama could commute under a program announced in 2014 by then Attorney General Eric Holder and Deputy Assistant Attorney General James Cole. They called on nonviolent federal drug war prisoners to seek clemency in April 2014.

"In 2010, President Obama signed the Fair Sentencing Act, reducing unfair disparities in sentences imposed on people for offenses involving different forms of cocaine, but there are still too many people in federal prison who were sentenced under the old regime -- and who, as a result, will have to spend far more time in prison than they would if sentenced today for exactly the same crime," said Holder. "This is simply not right."

Holder noted at the time that Obama had granted commutation to eight people serving time for crack offenses the previous December.

"The White House has indicated it wants to consider additional clemency applications, to restore a degree of justice, fairness, and proportionality for deserving individuals who do not pose a threat to public safety. The Justice Department is committed to recommending as many qualified applicants as possible for reduced sentences," Holder said.

Under Holder's criteria for clemency, low-level drug offenders who had served at least 10 years, had good conduct in prison, had no significant criminal history or connection to gangs, cartels, or organized crime, and who would probably receive a "substantially lower sentence" if convicted of the same offense today would be eligible for sentence cuts.

Of roughly 100,000 federal drug prisoners -- nearly half the entire federal prison population -- more than 36,000 applied for clemency. Many of them did not meet the criteria, but the Justice Department has reviewed nearly 9,500 that did. Of those, only the 562 have actually been granted clemency; applications are still pending for nearly 9,000 more. (An additional 8,000 pending applications are being handled by a consortium of private attorneys, the Clemency Project.)

Many of those might not make it to Obama's desk before the clock runs out on his term because the Justice Department has stumbled in administering the program. Thousands of prisoners doing harsh drug war sentences could lose their chance for early freedom because Justice didn't get around to hiring enough people to handle the flood of applications it generated.

That would undercut Obama's legacy of redressing drug war injustice. There are now only six months to go in his presidency, and nearly 18,000 prisoners who were told to seek clemency are now waiting for a response.

Here is President Obama addressing the commutation issue during an earlier series of sentence cuts:

Washington, DC
United States

Chronicle AM: Greece Moves Toward MedMJ, Italy to Debate Marijuana Legalization, More... (7/21/16)

There's a job opening for an experienced marijuana activist in DC, Libertarian Gary Johnson endorses California's legalization initiative, three European countries are making marijuana policy moves, and more.

It looks like medical marijuana is coming to Greece. (wikimedia.org)
Marijuana Policy

Libertarian Presidential Candidate Endorses California Legalization Initiative. Former Republican New Mexico Gov. Gary Johnson, who heads the Libertarian Party presidential ticket, has endorsed California's Prop 64 legalization initiative. "Why do I support it?" Johnson responded to a question while leaving the Republican National Convention. "Whether you agree with marijuana legalization or not, you have friends, family, coworkers that use marijuana," the former New Mexico governor said. "Are they criminal? No, they're not criminal." California Democrats have already endorsed the measure, and the national Democratic Party recently adopted a "pathway to legalization" as part of its platform. The Republicans, on the other hand, recently rejected supporting even medical marijuana.

Job Opening: NORML Seeks a New Director. In the wake of the resignation of long-time executive director Allen St. Pierre, the nation's largest marijuana consumer group is seeking a new leader. Click on the link for information about job requirements and more.

Drug Testing

New OSHA Rule Warns on Blanket After-Injury Drug Testing. The federal Occupational Safety and Health Administration (OSHA) has issued a final rule for the electronic submission of injury and illness data for certain employers, and in doing so, the agency warns that "OSHA believes the evidence in the rulemaking record shows that blanket post-injury drug testing policies deter proper reporting." Policies mandating automatic post-injury drug testing can discourage reporting of accidents and injuries, OSHA said, adding that blanket testing may be inappropriate: "Although drug testing of employees may be a reasonable workplace policy in some situations, it is often perceived as an invasion of privacy, so if an injury or illness is very unlikely to have been caused by employee drug use, or if the method of drug testing does not identify impairment but only use at some time in the recent past, requiring the employee to be drug tested may inappropriately deter reporting. To strike the appropriate balance here, drug testing policies should limit post-incident testing to situations in which employee drug use is likely to have contributed to the incident, and for which the drug test can accurately identify impairment caused by drug use."

Law Enforcement

Maryland Gives Up on Plan to Ban Letters to Prisoners to Fight Drug Smuggling. State corrections officials have withdrawn a proposed ban on sending letters to prison inmates in an a bid to stop the smuggling of drugs that can be soaked into photos and paper. Public Safety and Correctional Services Secretary Stephen Moyer had proposed the idea last month, but has now folded in the face of opposition from lawmakers and civil liberties advocates, who called the ban extreme and unconstitutional.

International

Italian Parliament Takes Up Marijuana Legalization on Monday. The Chamber of Deputies is expected to debate a legalization bill on Monday. The bill would legalize the possession of up to 15 grams at home and five grams outside the home, the cultivation of up to five plants for personal use, the creation of cannabis social clubs, and a regulated and licensed marijuana industry in the country.

Medical Marijuana Bill Filed in Ireland. An opposition member of the Dail has introduced a medical marijuana bill. Deputy Brid Smith of the Anti-Austerity Alliance/People Before Profit Party filed the measure, which envisions a Cannabis Regulation Authority and a licensing regime. The bill will be debated later as a private member's bill.

Greece Moving Forward on Medical Marijuana. The Health Ministry this week announced the formation of a working group of academics, psychiatrists, and scientific and legal advisers for the prime minister, the health ministry, and the justice ministry to begin examining issues around medical marijuana. The group's task is to propose feasible regulations for medical marijuana, and it is charged to submit its proposals by the end of October.

(This article was prepared by StoptheDrugWar.org's lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

Chronicle AM: Obama to Sign Opioids Bill, CO Legal MJ Fueling Economic Growth, More... (7/15/16)

A new report finds legal marijuana has been good for Colorado's economy, the White House announces President Obama will sign CARA, and more.

The president will sign the Comprehensive Addiction and Recovery Act despite the lack of adequate funding. (whitehouse.gov)
Marijuana Policy

Report Finds Legal Marijuana Bolstering Retail, Manufacturing in Colorado. In a new report, the University of Colorado Leeds School of Business finds that the state's marijuana industry is bumping up retail sales and hiring in manufacturing. Recreational cannabis sales began in 2014. That year, "We had a 3.5% increase in employment. In 2015, a 4.9% increase in food-manufacturing employment," the report said. "The data doesn't allow us to slice and dice to say, 'These are indeed edibles or not,' but the recognition is this is where they would be classified." Likewise, chemical manufacturing jobs vanished at a rate of 2.2% a year from 2002 to 2012, but increased 2.1% in 2013, 1.4% in 2014, and 3.9% last year. Chemical manufacturing includes producing cannabis oils.

Heroin and Prescription Opioids

Obama Will Sign Opioids Bill Despite Lack of Funding. President Obama will sign into law the Comprehensive Addiction and Recovery Act (S. 524) even though Congress failed to adequately fund it, the White House said Wednesday. The bill "falls far short" of necessary funding, but Obama will sign it "because some action is better than none." More funds could be appropriated in the future, but that's by no means a done deal.

International

Peru Takes Aim at Coca Cultivation in the VRAEM. The country's anti-drug agency, DEVIDA, said Thursday in is ready to eradicate coca plants in the remote and lawless Valleys of the Rio, Apurimac, and Mantaro Rivers (VRAEM) region of south-central Peru. The government has held off on eradication in the region, a major coca producer and home to a remnant of the Shining Path rebels. About three-quarters of the country's coca is grown there, and DEVIDA is ready to go after it. "Today I can say that the conditions are now entirely there for a drastic reduction in the coverage of coca in the VRAEM," Devida chief Alberto Otarola said in a news conference. "No part of Peru should be exempt from the rule of law."

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School